+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Antacids Market by Form, Active Ingredient, Distribution Channel, Price Tier - Global Forecast to 2030

  • PDF Icon

    Report

  • 183 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 4904677
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The antacids market is experiencing rapid shifts as trends in consumer wellness, technological innovation, and global distribution reshape product strategy and opportunity. Senior decision-makers require current, actionable market intelligence to proactively address shifting dynamics and position for future growth in this competitive landscape.

Market Snapshot: Antacids Market Growth and Opportunity

The antacids market grew from USD 7.24 billion in 2024 to USD 7.67 billion in 2025 and is on track to reach USD 10.18 billion by 2030, with a CAGR of 5.83%. Market expansion is driven by increased consumer awareness of digestive health, rising prevalence of gastrointestinal issues, and the integration of advanced product formats. Growing interest in prevention and self-care, along with digital enablement, is expanding touchpoints and extending antacid usage beyond traditional segments. These dynamics are supported by robust competition and greater innovation in both formulation and delivery mechanisms.

Scope & Segmentation

This research rigorously analyzes the antacids market across all major segmentation layers, uncovering unique drivers and barriers for each category:

  • Form Types: Effervescent tablets, gels, liquids, powders, tablets
  • Active Ingredients: Aluminum hydroxide, calcium carbonate, magnesium hydroxide, sodium bicarbonate, combination formulations
  • Distribution Channels: Hospital pharmacy, online retail, retail pharmacy, supermarket/hypermarket
  • Price Tiers: Economy, mid-range, premium
  • Regional Coverage: Americas (United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (United Kingdom, Germany, France, Russia, Italy, Spain, United Arab Emirates, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland), Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan)
  • Leading Companies Profiled: Haleon plc, Johnson & Johnson, Reckitt Benckiser Group plc, Sanofi SA, Bayer AG, Perrigo Company plc, Teva Pharmaceutical Industries Ltd, Viatris Inc., Dr. Reddy’s Laboratories Ltd, Novartis International AG

Relevance of Segmentation, Regional Markets, and Technology Trends

Segment analysis highlights evolving consumer preferences, such as demand for alternative delivery formats and functional ingredients. Regional diversity requires tailored strategies, with differing regulatory climates, supply chain requirements, and digital adoption affecting access and growth. Technology trends, including rapid-dissolve and bioadhesive delivery systems, support market differentiation and address emerging consumer needs.

Key Takeaways for Decision-Makers

  • Prevailing trends in preventative health and self-medication are transforming antacids from reactive treatments into daily wellness integrators, broadening market appeal and usage frequency.
  • Product innovation—especially in chewable, effervescent, and rapid-dissolve formulations—positions manufacturers to capture consumers seeking more palatable and convenient options.
  • Expansion of digital platforms and telemedicine channels is reshaping buying behavior, increasing both reach and consumer education opportunities, and favoring brands with strong omnichannel strategies.
  • Stricter regulations and labeling requirements drive greater investment in clinical validation, transparent marketing, and quality assurance to maintain compliance and competitive edge.
  • Strategic alliances, licensing, and mergers are accelerating new market entry and geographical expansion, supporting agile adaptation to diverse market conditions.
  • Supply chain resilience, including process optimization and diversified sourcing, is critical in responding to changing market dynamics and regulatory disruptions.

Tariff Impact

The 2025 implementation of new tariffs in the United States increased costs across the antacid supply chain, impacting sourcing strategies and profit margins. Companies have responded by increasing domestic ingredient procurement, renegotiating supplier contracts, and investing in manufacturing efficiencies to safeguard continuity and competitiveness. Pricing strategies have shifted, with some firms absorbing costs while others have adjusted channel pricing. Intensified competition in mid-range segments and proactive global procurement diversification now define market resilience in response to trade policy changes.

Methodology & Data Sources

This report leverages a robust mixed-methods framework, combining primary interviews with market experts, supply chain managers, and commercial strategists with secondary research from authoritative journals, financial filings, and regulatory documents. Data triangulation, expert validation, and peer reviews underpin every segment and regional finding, ensuring transparency and accuracy.

Why This Report Matters

  • Enables senior leaders to anticipate and strategically respond to evolving consumer behavior, regulatory benchmarks, and supply chain fluctuations in the antacids market.
  • Delivers granular, segmented insights by form, active ingredient, channel, region, and price tier—supporting precise targeting and resource allocation.
  • Provides actionable guidance on emerging innovation, partnership opportunities, and data-driven market entry decisions.

Conclusion

The antacids market is characterized by convergence between scientific advancement, regulatory rigor, and shifting consumer preferences. Senior stakeholders who deploy strategies aligned to these currents will be positioned to thrive amid complexity and change in global gastrointestinal care.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Antacids Market, by Form
8.1. Introduction
8.2. Effervescent Tablets
8.3. Gels
8.4. Liquids
8.5. Powders
8.6. Tablets
9. Antacids Market, by Active Ingredient
9.1. Introduction
9.2. Aluminum Hydroxide
9.3. Calcium Carbonate
9.4. Combination Formulations
9.5. Magnesium Hydroxide
9.6. Sodium Bicarbonate
10. Antacids Market, by Distribution Channel
10.1. Introduction
10.2. Hospital Pharmacy
10.3. Online Retail
10.4. Retail Pharmacy
10.5. Supermarket/Hypermarket
11. Antacids Market, by Price Tier
11.1. Introduction
11.2. Economy
11.3. Mid-Range
11.4. Premium
12. Americas Antacids Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Antacids Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Antacids Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Haleon plc
15.3.2. Johnson & Johnson
15.3.3. Reckitt Benckiser Group plc
15.3.4. Sanofi SA
15.3.5. Bayer AG
15.3.6. Perrigo Company plc
15.3.7. Teva Pharmaceutical Industries Ltd
15.3.8. Viatris Inc.
15.3.9. Dr. Reddy’s Laboratories Ltd
15.3.10. Novartis International AG
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. ANTACIDS MARKET MULTI-CURRENCY
FIGURE 2. ANTACIDS MARKET MULTI-LANGUAGE
FIGURE 3. ANTACIDS MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL ANTACIDS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL ANTACIDS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL ANTACIDS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL ANTACIDS MARKET SIZE, BY FORM, 2024 VS 2030 (%)
FIGURE 8. GLOBAL ANTACIDS MARKET SIZE, BY FORM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL ANTACIDS MARKET SIZE, BY ACTIVE INGREDIENT, 2024 VS 2030 (%)
FIGURE 10. GLOBAL ANTACIDS MARKET SIZE, BY ACTIVE INGREDIENT, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 12. GLOBAL ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL ANTACIDS MARKET SIZE, BY PRICE TIER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL ANTACIDS MARKET SIZE, BY PRICE TIER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS ANTACIDS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS ANTACIDS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES ANTACIDS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES ANTACIDS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ANTACIDS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA ANTACIDS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC ANTACIDS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC ANTACIDS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ANTACIDS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. ANTACIDS MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. ANTACIDS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL ANTACIDS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL ANTACIDS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL ANTACIDS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL ANTACIDS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL ANTACIDS MARKET SIZE, BY EFFERVESCENT TABLETS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL ANTACIDS MARKET SIZE, BY GELS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL ANTACIDS MARKET SIZE, BY LIQUIDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL ANTACIDS MARKET SIZE, BY POWDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL ANTACIDS MARKET SIZE, BY TABLETS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL ANTACIDS MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL ANTACIDS MARKET SIZE, BY ALUMINUM HYDROXIDE, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL ANTACIDS MARKET SIZE, BY CALCIUM CARBONATE, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL ANTACIDS MARKET SIZE, BY COMBINATION FORMULATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL ANTACIDS MARKET SIZE, BY MAGNESIUM HYDROXIDE, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL ANTACIDS MARKET SIZE, BY SODIUM BICARBONATE, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL ANTACIDS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL ANTACIDS MARKET SIZE, BY ONLINE RETAIL, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL ANTACIDS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL ANTACIDS MARKET SIZE, BY SUPERMARKET/HYPERMARKET, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL ANTACIDS MARKET SIZE, BY PRICE TIER, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL ANTACIDS MARKET SIZE, BY ECONOMY, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL ANTACIDS MARKET SIZE, BY MID-RANGE, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL ANTACIDS MARKET SIZE, BY PREMIUM, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. AMERICAS ANTACIDS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 28. AMERICAS ANTACIDS MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 29. AMERICAS ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 30. AMERICAS ANTACIDS MARKET SIZE, BY PRICE TIER, 2018-2030 (USD MILLION)
TABLE 31. AMERICAS ANTACIDS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 32. UNITED STATES ANTACIDS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 33. UNITED STATES ANTACIDS MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 34. UNITED STATES ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 35. UNITED STATES ANTACIDS MARKET SIZE, BY PRICE TIER, 2018-2030 (USD MILLION)
TABLE 36. UNITED STATES ANTACIDS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 37. CANADA ANTACIDS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 38. CANADA ANTACIDS MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 39. CANADA ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 40. CANADA ANTACIDS MARKET SIZE, BY PRICE TIER, 2018-2030 (USD MILLION)
TABLE 41. MEXICO ANTACIDS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 42. MEXICO ANTACIDS MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 43. MEXICO ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 44. MEXICO ANTACIDS MARKET SIZE, BY PRICE TIER, 2018-2030 (USD MILLION)
TABLE 45. BRAZIL ANTACIDS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 46. BRAZIL ANTACIDS MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 47. BRAZIL ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 48. BRAZIL ANTACIDS MARKET SIZE, BY PRICE TIER, 2018-2030 (USD MILLION)
TABLE 49. ARGENTINA ANTACIDS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 50. ARGENTINA ANTACIDS MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 51. ARGENTINA ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 52. ARGENTINA ANTACIDS MARKET SIZE, BY PRICE TIER, 2018-2030 (USD MILLION)
TABLE 53. EUROPE, MIDDLE EAST & AFRICA ANTACIDS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 54. EUROPE, MIDDLE EAST & AFRICA ANTACIDS MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 55. EUROPE, MIDDLE EAST & AFRICA ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 56. EUROPE, MIDDLE EAST & AFRICA ANTACIDS MARKET SIZE, BY PRICE TIER, 2018-2030 (USD MILLION)
TABLE 57. EUROPE, MIDDLE EAST & AFRICA ANTACIDS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 58. UNITED KINGDOM ANTACIDS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 59. UNITED KINGDOM ANTACIDS MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 60. UNITED KINGDOM ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 61. UNITED KINGDOM ANTACIDS MARKET SIZE, BY PRICE TIER, 2018-2030 (USD MILLION)
TABLE 62. GERMANY ANTACIDS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 63. GERMANY ANTACIDS MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 64. GERMANY ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 65. GERMANY ANTACIDS MARKET SIZE, BY PRICE TIER, 2018-2030 (USD MILLION)
TABLE 66. FRANCE ANTACIDS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 67. FRANCE ANTACIDS MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 68. FRANCE ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 69. FRANCE ANTACIDS MARKET SIZE, BY PRICE TIER, 2018-2030 (USD MILLION)
TABLE 70. RUSSIA ANTACIDS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 71. RUSSIA ANTACIDS MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 72. RUSSIA ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 73. RUSSIA ANTACIDS MARKET SIZE, BY PRICE TIER, 2018-2030 (USD MILLION)
TABLE 74. ITALY ANTACIDS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 75. ITALY ANTACIDS MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 76. ITALY ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 77. ITALY ANTACIDS MARKET SIZE, BY PRICE TIER, 2018-2030 (USD MILLION)
TABLE 78. SPAIN ANTACIDS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 79. SPAIN ANTACIDS MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 80. SPAIN ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 81. SPAIN ANTACIDS MARKET SIZE, BY PRICE TIER, 2018-2030 (USD MILLION)
TABLE 82. UNITED ARAB EMIRATES ANTACIDS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 83. UNITED ARAB EMIRATES ANTACIDS MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 84. UNITED ARAB EMIRATES ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 85. UNITED ARAB EMIRATES ANTACIDS MARKET SIZE, BY PRICE TIER, 2018-2030 (USD MILLION)
TABLE 86. SAUDI ARABIA ANTACIDS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 87. SAUDI ARABIA ANTACIDS MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 88. SAUDI ARABIA ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 89. SAUDI ARABIA ANTACIDS MARKET SIZE, BY PRICE TIER, 2018-2030 (USD MILLION)
TABLE 90. SOUTH AFRICA ANTACIDS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 91. SOUTH AFRICA ANTACIDS MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 92. SOUTH AFRICA ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 93. SOUTH AFRICA ANTACIDS MARKET SIZE, BY PRICE TIER, 2018-2030 (USD MILLION)
TABLE 94. DENMARK ANTACIDS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 95. DENMARK ANTACIDS MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 96. DENMARK ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 97. DENMARK ANTACIDS MARKET SIZE, BY PRICE TIER, 2018-2030 (USD MILLION)
TABLE 98. NETHERLANDS ANTACIDS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 99. NETHERLANDS ANTACIDS MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 100. NETHERLANDS ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 101. NETHERLANDS ANTACIDS MARKET SIZE, BY PRICE TIER, 2018-2030 (USD MILLION)
TABLE 102. QATAR ANTACIDS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 103. QATAR ANTACIDS MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 104. QATAR ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 105. QATAR ANTACIDS MARKET SIZE, BY PRICE TIER, 2018-2030 (USD MILLION)
TABLE 106. FINLAND ANTACIDS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 107. FINLAND ANTACIDS MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 108. FINLAND ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 109. FINLAND ANTACIDS MARKET SIZE, BY PRICE TIER, 2018-2030 (USD MILLION)
TABLE 110. SWEDEN ANTACIDS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 111. SWEDEN ANTACIDS MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 112. SWEDEN ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 113. SWEDEN ANTACIDS MARKET SIZE, BY PRICE TIER, 2018-2030 (USD MILLION)
TABLE 114. NIGERIA ANTACIDS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 115. NIGERIA ANTACIDS MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 116. NIGERIA ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 117. NIGERIA ANTACIDS MARKET SIZE, BY PRICE TIER, 2018-2030 (USD MILLION)
TABLE 118. EGYPT ANTACIDS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 119. EGYPT ANTACIDS MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 120. EGYPT ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 121. EGYPT ANTACIDS MARKET SIZE, BY PRICE TIER, 2018-2030 (USD MILLION)
TABLE 122. TURKEY ANTACIDS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 123. TURKEY ANTACIDS MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 124. TURKEY ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 125. TURKEY ANTACIDS MARKET SIZE, BY PRICE TIER, 2018-2030 (USD MILLION)
TABLE 126. ISRAEL ANTACIDS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 127. ISRAEL ANTACIDS MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 128. ISRAEL ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 129. ISRAEL ANTACIDS MARKET SIZE, BY PRICE TIER, 2018-2030 (USD MILLION)
TABLE 130. NORWAY ANTACIDS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 131. NORWAY ANTACIDS MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 132. NORWAY ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 133. NORWAY ANTACIDS MARKET SIZE, BY PRICE TIER, 2018-2030 (USD MILLION)
TABLE 134. POLAND ANTACIDS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 135. POLAND ANTACIDS MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 136. POLAND ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 137. POLAND ANTACIDS MARKET SIZE, BY PRICE TIER, 2018-2030 (USD MILLION)
TABLE 138. SWITZERLAND ANTACIDS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 139. SWITZERLAND ANTACIDS MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 140. SWITZERLAND ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 141. SWITZERLAND ANTACIDS MARKET SIZE, BY PRICE TIER, 2018-2030 (USD MILLION)
TABLE 142. ASIA-PACIFIC ANTACIDS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 143. ASIA-PACIFIC ANTACIDS MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 144. ASIA-PACIFIC ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 145. ASIA-PACIFIC ANTACIDS MARKET SIZE, BY PRICE TIER, 2018-2030 (USD MILLION)
TABLE 146. ASIA-PACIFIC ANTACIDS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 147. CHINA ANTACIDS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 148. CHINA ANTACIDS MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 149. CHINA ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 150. CHINA ANTACIDS MARKET SIZE, BY PRICE TIER, 2018-2030 (USD MILLION)
TABLE 151. INDIA ANTACIDS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 152. INDIA ANTACIDS MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 153. INDIA ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 154. INDIA ANTACIDS MARKET SIZE, BY PRICE TIER, 2018-2030 (USD MILLION)
TABLE 155. JAPAN ANTACIDS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 156. JAPAN ANTACIDS MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 157. JAPAN ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 158. JAPAN ANTACIDS MARKET SIZE, BY PRICE TIER, 2018-2030 (USD MILLION)
TABLE 159. AUSTRALIA ANTACIDS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 160. AUSTRALIA ANTACIDS MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 161. AUSTRALIA ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 162. AUSTRALIA ANTACIDS MARKET SIZE, BY PRICE TIER, 2018-2030 (USD MILLION)
TABLE 163. SOUTH KOREA ANTACIDS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 164. SOUTH KOREA ANTACIDS MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 165. SOUTH KOREA ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 166. SOUTH KOREA ANTACIDS MARKET SIZE, BY PRICE TIER, 2018-2030 (USD MILLION)
TABLE 167. INDONESIA ANTACIDS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 168. INDONESIA ANTACIDS MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 169. INDONESIA ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 170. INDONESIA ANTACIDS MARKET SIZE, BY PRICE TIER, 2018-2030 (USD MILLION)
TABLE 171. THAILAND ANTACIDS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 172. THAILAND ANTACIDS MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 173. THAILAND ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 174. THAILAND ANTACIDS MARKET SIZE, BY PRICE TIER, 2018-2030 (USD MILLION)
TABLE 175. PHILIPPINES ANTACIDS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 176. PHILIPPINES ANTACIDS MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 177. PHILIPPINES ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 178. PHILIPPINES ANTACIDS MARKET SIZE, BY PRICE TIER, 2018-2030 (USD MILLION)
TABLE 179. MALAYSIA ANTACIDS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 180. MALAYSIA ANTACIDS MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 181. MALAYSIA ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 182. MALAYSIA ANTACIDS MARKET SIZE, BY PRICE TIER, 2018-2030 (USD MILLION)
TABLE 183. SINGAPORE ANTACIDS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 184. SINGAPORE ANTACIDS MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 185. SINGAPORE ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 186. SINGAPORE ANTACIDS MARKET SIZE, BY PRICE TIER, 2018-2030 (USD MILLION)
TABLE 187. VIETNAM ANTACIDS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 188. VIETNAM ANTACIDS MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 189. VIETNAM ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 190. VIETNAM ANTACIDS MARKET SIZE, BY PRICE TIER, 2018-2030 (USD MILLION)
TABLE 191. TAIWAN ANTACIDS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 192. TAIWAN ANTACIDS MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 193. TAIWAN ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 194. TAIWAN ANTACIDS MARKET SIZE, BY PRICE TIER, 2018-2030 (USD MILLION)
TABLE 195. ANTACIDS MARKET SHARE, BY KEY PLAYER, 2024
TABLE 196. ANTACIDS MARKET, FPNV POSITIONING MATRIX, 2024

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Antacids market report include:
  • Haleon plc
  • Johnson & Johnson
  • Reckitt Benckiser Group plc
  • Sanofi SA
  • Bayer AG
  • Perrigo Company plc
  • Teva Pharmaceutical Industries Ltd
  • Viatris Inc.
  • Dr. Reddy’s Laboratories Ltd
  • Novartis International AG

Table Information